Targeting Alpha-Synuclein as a Treatment for Parkinson’s Disease . International Journal of Pharmaceutical and Healthcare Innovation, [S. l.], v. 1, n. 04, p. 296–307, 2024. DOI: 10.62752/9v9h6s45. Disponível em: https://ijphi.com/index.php/files/article/view/129.. Acesso em: 22 dec. 2024.